Literature DB >> 34102143

Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem-Cell Transplantation in Adults: A French Société Francophone de Greffe de Moelle et Thérapie Cellulaire Survey.

Helene Salvator1, Colas Tcherakian2, Natacha Maillard3, Serge Milin4, Anne Bergeron5, Louise Bondeelle5, Veronique Meignin6, Stephanie Nguyen7, Laetitia Souchet8, Sarah Guenounou9, Solène M Evrard10, Marie-Therese Rubio11, Marie Robin12, Simona Sestili13, Eolia Brissot14, Anne Fajac15, Emilie Catherinot2, Claire Givel2, Alexandre Chabrol2, Céline Goyard2, Elisabeth Longchampt16, Marie-Laure Chabi-Charvillat17, Jean-Francois Bernaudin18, Louis-Jean Couderc19.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34102143     DOI： 10.1016/j.chest.2021.05.056

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  2 in total

1.  Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report.

Authors:  Hanne Beeckmans; Gene P L Ambrocio; Saskia Bos; Astrid Vermaut; Vincent Geudens; Arno Vanstapel; Bart M Vanaudenaerde; Frans De Baets; Thomas L A Malfait; Marie-Paule Emonds; Dirk E Van Raemdonck; Hélène M Schoemans; Robin Vos
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

2.  Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability.

Authors:  Nikola Mantov; Mathilde Zrounba; Marion Brollo; S Grassin-Delyle; Matthieu Glorion; Mélanie David; Emmanuel Naline; Philippe Devillier; Hélène Salvator
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.